Us Bancorp \De\ Oric Pharmaceuticals, Inc. Transaction History

Us Bancorp \De\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$2.7 - $7.07 $186 - $487	-69 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$4.54 - $16.1 $4,281 - $15,182	-943 Reduced 93.18%	69 $0
Q4 2021 Feb 11, 2022	SELL	$12.01 - $20.3 $4,119 - $6,962	-343 Reduced 25.31%	1,012 $15,000
Q3 2021 Nov 10, 2021	BUY	$15.9 - $25.22 $21,544 - $34,173	1,355 New	1,355 $28,000

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.